Community acquired pneumonia incidence among children less than 5 years of age in Concordia, Argentina: vaccination impact

OBJECTIVE: To measure the effectiveness of pneumococcal conjugated vaccine (PCV13) against Community Acquired Pneumonia (CAP) and invasive pneumococcal disease, 2 years after the vaccine (2+1) was included into the National Immunization Program of Argentina, and to describe variables associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruvinsky, Raúl O., Rearte, Analía, Kupervaser, Judit, Gentile, Fernando, Haidar, Adriana, Cafure, Maria E., Tito, Maria Elisa, Avaro, Federico, Cortiana, Cristina, Cozzani, Hugo, Véliz, Omar, Fossati, Sofia, Regueira, Mabel, Vizzotti, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Organización Panamericana de la Salud 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386047/
https://www.ncbi.nlm.nih.gov/pubmed/31093195
http://dx.doi.org/10.26633/RPSP.2018.167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386047/
https://www.ncbi.nlm.nih.gov/pubmed/31093195
http://dx.doi.org/10.26633/RPSP.2018.167

Ejemplares similares